Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccines
Clinical trial NCT01905215 · COMPLETED
Trial details
- NCT number
- NCT01905215
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-22
- Primary completion
- 2014-04-09
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.